Improving Access to Healthcare

Primary tabs

Improving Access to Healthcare

Each day, Sanofi’s 110,000 employees seek to preserve the health of people all over the world and improve access to care. Working with our partners, we have the resources and the expertise to meet this challenge. 

  • Access to Care: Access to quality healthcare is the true challenge. Improving care infrastructures and policies, implementing differentiated pricing programs, and contributing to local economic development are some of the areas where we make a difference each day. Read more…
  • Innovation for Patients: Innovation is both a mindset and a goal shared by everyone at Sanofi. Our ongoing commitment drives the development of innovative products and services adapted to the needs of patients and communities. Read more…
  • Patient Safety: Ensuring the safety and quality of our products is one of Sanofi’s key priorities. Insofar as possible, we seek to manage the risks associated with the use of our products. Read more…

FMRs from this campaign

Every Child, In Every Neighborhood, Deserves a Doctor
Recently I met Isani Castro, a young woman who has been a patient of Children’s Health Fund’s (CHF) New York project since she was five years old.  When she first came to CHF, Isani had a serious eye problem that affected her ability to learn and thrive.  Thankfully, a CHF mobile medical clinic drove into her New York neighborhoo
Apr 4, 2014 3:00 PM ET
Merial Announces EU Approval For NexGard®
February 19, 2014 /3BL Media/ - Sanofi and its animal health division, Merial, today announced that the European Commission has approved NexGard® (afoxolaner) for the treatment of flea and tick infestations in dogs. One oral treatment kills fleas for at least 5 weeks and ticks for up to one month.
Feb 20, 2014 9:00 AM ET
Sanofi Patient Connection™...A Look Back at the First Year
April 26, 2013 /3BL Media/ - In 2012 Sanofi US launched “Sanofi Patient Connection (SPC)” a cutting-edge program to provide reimbursement support and patient assistance to help patients access our products, additional services and resources that may be useful in the comprehensive management of their diseases.
Apr 26, 2013 9:00 AM ET
Sanofi Pasteur to Provide 1.7 Million Doses of Oral Polio Vaccine from 2013 to 2017 for Polio Eradication
April 24, 2013 /3BL Media/ - Sanofi Pasteur, the vaccines division of Sanofi, announced today its commitment to provide 1.7 billion doses of oral polio vaccine (OPV) to support the Global Polio eradication Initiative’s (GPEI) strategy to eradicate polio this decade. The doses of OPV will be delivered through 2017 for GPEI polio vaccination program.
Apr 24, 2013 12:00 PM ET
Sanofi Improves Rank on Access to Medicines Index
PARIS, November 28, 2012 /3BL Media/ - Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that it ranked third among twenty pharmaceutical companies on the 2012 Access to Medicine Index (ATM Index) created by the Access to Medicine Foundation, an international non-profit organization dedicated to improving access t
Nov 28, 2012 12:00 PM ET

Pages